Salerno Named to Pierian Biosciences Board of Directors

Former CEO of Susan G. Komen Brings Health Policy, Operational Expertise to Board Leadership NASHVILLE, Tenn., April 18, 2017 – Pierian Biosciences, the premier developer of life science technologies providing treatment-directing data to aid physicians in selecting...

Immunotherapy Making Strides at ASCO-SITC Immuno-Oncology Symposium

In late February, the American Society of Clinical Oncology (ASCO) partnered with the Society for Immunotherapy of Cancer (SITC) to host the first ASCO-SITC Clinical Immuno-Oncology Symposium, held in Orlando. We learned, along with 1000 other attendees, about the...

Response to FiercePharma Article

CLIENT: Pierian Biosciences DATE: February 17, 2017 PROJECT: PR – Blog post – Response to FiercePharma article Author: Robert Henry A recent FiercePharma article on the top 15 cancer drugs for 2022 predicts they will total nearly $90 billion in sales. That’s a...